ID

18942

Beschreibung

Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00103428

Link

https://clinicaltrials.gov/show/NCT00103428

Stichworte

Versionen (1)
  1. 25.11.16 25.11.16 -
Hochgeladen am

25. November 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer NCT00103428

Englisch

Eligibility Prostate Cancer NCT00103428

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed adenocarcinoma of the prostate
Beschreibung

Adenocarcinoma of prostate

Datentyp

boolean

Alias
UMLS CUI [1]
C0007112
metastatic prostate cancer deemed to be unresponsive or refractory to hormone therapy (after discontinuation of anti-androgen therapy)
Beschreibung

Metastatic Prostate Carcinoma Hormone Therapy refractory | Antiandrogen therapy Discontinued

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0936223
UMLS CUI [1,2]
C0279025
UMLS CUI [1,3]
C0205269
UMLS CUI [2,1]
C0279492
UMLS CUI [2,2]
C1444662
detectable metastases by bone scan, and/or ct scan, and/or mri, and/or cxr
Beschreibung

Neoplasm Metastasis Detectable bone scan | Neoplasm Metastasis Detectable CT scan | Neoplasm Metastasis Detectable MRI | Neoplasm Metastasis Detectable Chest X-ray

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C3830527
UMLS CUI [1,3]
C0203668
UMLS CUI [2,1]
C0027627
UMLS CUI [2,2]
C3830527
UMLS CUI [2,3]
C0040405
UMLS CUI [3,1]
C0027627
UMLS CUI [3,2]
C3830527
UMLS CUI [3,3]
C0024485
UMLS CUI [4,1]
C0027627
UMLS CUI [4,2]
C3830527
UMLS CUI [4,3]
C0039985
ecog performance status 0-1
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
transitional cell, small cell, neuroendocrine, or squamous cell prostate cancer
Beschreibung

transitional cell carcinoma of prostate | Small cell carcinoma of prostate | Prostate Neuroendocrine Neoplasm | Squamous cell carcinoma of prostate

Datentyp

boolean

Alias
UMLS CUI [1]
C2145466
UMLS CUI [2]
C1300585
UMLS CUI [3]
C1335515
UMLS CUI [4]
C1302530
history of deep vein thrombosis or pulmonary embolus
Beschreibung

Deep Vein Thrombosis | Pulmonary Embolism

Datentyp

boolean

Alias
UMLS CUI [1]
C0149871
UMLS CUI [2]
C0034065
patients taking anticoagulants (such as coumadin or heparin). the use of aspirin while on study is acceptable.
Beschreibung

Anticoagulants | Coumadin | Heparin | Aspirin

Datentyp

boolean

Alias
UMLS CUI [1]
C0003280
UMLS CUI [2]
C0699129
UMLS CUI [3]
C0019134
UMLS CUI [4]
C0004057
history of a bleeding disorder or recent clinically significant bleeding
Beschreibung

Blood Coagulation Disorders | Hemorrhage Clinical Significance

Datentyp

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2,1]
C0019080
UMLS CUI [2,2]
C2826293
seropositive for hiv
Beschreibung

HIV Seropositivity

Datentyp

boolean

Alias
UMLS CUI [1]
C0019699
history of hepatitis b, hepatitis c, or chronic liver disease
Beschreibung

Hepatitis B | Hepatitis C | Chronic liver disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
UMLS CUI [3]
C0341439
prior gene therapy or immunotherapy
Beschreibung

gene therapy | Immunotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0017296
UMLS CUI [2]
C0021083
prior chemotherapy for prostate cancer
Beschreibung

Chemotherapy Used to Treat Prostate Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C1880062
radiation therapy within 4 weeks of the first treatment.
Beschreibung

Therapeutic radiology procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C1522449
history of myocardial infarction within 6 months of the first treatment
Beschreibung

Myocardial Infarction

Datentyp

boolean

Alias
UMLS CUI [1]
C0027051
history of cerebrovascular accident
Beschreibung

Cerebrovascular accident

Datentyp

boolean

Alias
UMLS CUI [1]
C0038454
history of previous malignancy, except for the following: adequately treated basal cell or squamous cell skin cancer, superficial bladder cancer, adequately treated stage i or ii cancer currently in complete remission, or any other cancer that has been in complete remission for at least 5 years
Beschreibung

Malignant Neoplasms | Basal cell carcinoma Treated | Squamous cell carcinoma of skin Treated | Carcinoma of urinary bladder, superficial | TNM clinical staging Treated In complete remission | Malignant Neoplasm In complete remission

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0007117
UMLS CUI [2,2]
C1522326
UMLS CUI [3,1]
C0553723
UMLS CUI [3,2]
C1522326
UMLS CUI [4]
C1336527
UMLS CUI [5,1]
C3258246
UMLS CUI [5,2]
C1522326
UMLS CUI [5,3]
C0677874
UMLS CUI [6,1]
C0006826
UMLS CUI [6,2]
C0677874
evidence of active prostatitis
Beschreibung

prostatitis Evidence of

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0033581
UMLS CUI [1,2]
C0332120
known hypersensitivity to docetaxel or to other drugs formulated with polysorbate 80
Beschreibung

Hypersensitivity docetaxel | Hypersensitivity Polysorbate 80 Pharmaceutical Formulation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0246415
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0032601
UMLS CUI [2,3]
C1705957
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Prostate Cancer NCT00103428

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate
Item
histologically confirmed adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
Metastatic Prostate Carcinoma Hormone Therapy refractory | Antiandrogen therapy Discontinued
Item
metastatic prostate cancer deemed to be unresponsive or refractory to hormone therapy (after discontinuation of anti-androgen therapy)
boolean
C0936223 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
C0205269 (UMLS CUI [1,3])
C0279492 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
Neoplasm Metastasis Detectable bone scan | Neoplasm Metastasis Detectable CT scan | Neoplasm Metastasis Detectable MRI | Neoplasm Metastasis Detectable Chest X-ray
Item
detectable metastases by bone scan, and/or ct scan, and/or mri, and/or cxr
boolean
C0027627 (UMLS CUI [1,1])
C3830527 (UMLS CUI [1,2])
C0203668 (UMLS CUI [1,3])
C0027627 (UMLS CUI [2,1])
C3830527 (UMLS CUI [2,2])
C0040405 (UMLS CUI [2,3])
C0027627 (UMLS CUI [3,1])
C3830527 (UMLS CUI [3,2])
C0024485 (UMLS CUI [3,3])
C0027627 (UMLS CUI [4,1])
C3830527 (UMLS CUI [4,2])
C0039985 (UMLS CUI [4,3])
ECOG performance status
Item
ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
transitional cell carcinoma of prostate | Small cell carcinoma of prostate | Prostate Neuroendocrine Neoplasm | Squamous cell carcinoma of prostate
Item
transitional cell, small cell, neuroendocrine, or squamous cell prostate cancer
boolean
C2145466 (UMLS CUI [1])
C1300585 (UMLS CUI [2])
C1335515 (UMLS CUI [3])
C1302530 (UMLS CUI [4])
Deep Vein Thrombosis | Pulmonary Embolism
Item
history of deep vein thrombosis or pulmonary embolus
boolean
C0149871 (UMLS CUI [1])
C0034065 (UMLS CUI [2])
Anticoagulants | Coumadin | Heparin | Aspirin
Item
patients taking anticoagulants (such as coumadin or heparin). the use of aspirin while on study is acceptable.
boolean
C0003280 (UMLS CUI [1])
C0699129 (UMLS CUI [2])
C0019134 (UMLS CUI [3])
C0004057 (UMLS CUI [4])
Blood Coagulation Disorders | Hemorrhage Clinical Significance
Item
history of a bleeding disorder or recent clinically significant bleeding
boolean
C0005779 (UMLS CUI [1])
C0019080 (UMLS CUI [2,1])
C2826293 (UMLS CUI [2,2])
HIV Seropositivity
Item
seropositive for hiv
boolean
C0019699 (UMLS CUI [1])
Hepatitis B | Hepatitis C | Chronic liver disease
Item
history of hepatitis b, hepatitis c, or chronic liver disease
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0341439 (UMLS CUI [3])
gene therapy | Immunotherapy
Item
prior gene therapy or immunotherapy
boolean
C0017296 (UMLS CUI [1])
C0021083 (UMLS CUI [2])
Chemotherapy Used to Treat Prostate Carcinoma
Item
prior chemotherapy for prostate cancer
boolean
C1880062 (UMLS CUI [1])
Therapeutic radiology procedure
Item
radiation therapy within 4 weeks of the first treatment.
boolean
C1522449 (UMLS CUI [1])
Myocardial Infarction
Item
history of myocardial infarction within 6 months of the first treatment
boolean
C0027051 (UMLS CUI [1])
Cerebrovascular accident
Item
history of cerebrovascular accident
boolean
C0038454 (UMLS CUI [1])
Malignant Neoplasms | Basal cell carcinoma Treated | Squamous cell carcinoma of skin Treated | Carcinoma of urinary bladder, superficial | TNM clinical staging Treated In complete remission | Malignant Neoplasm In complete remission
Item
history of previous malignancy, except for the following: adequately treated basal cell or squamous cell skin cancer, superficial bladder cancer, adequately treated stage i or ii cancer currently in complete remission, or any other cancer that has been in complete remission for at least 5 years
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0553723 (UMLS CUI [3,1])
C1522326 (UMLS CUI [3,2])
C1336527 (UMLS CUI [4])
C3258246 (UMLS CUI [5,1])
C1522326 (UMLS CUI [5,2])
C0677874 (UMLS CUI [5,3])
C0006826 (UMLS CUI [6,1])
C0677874 (UMLS CUI [6,2])
prostatitis Evidence of
Item
evidence of active prostatitis
boolean
C0033581 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
Hypersensitivity docetaxel | Hypersensitivity Polysorbate 80 Pharmaceutical Formulation
Item
known hypersensitivity to docetaxel or to other drugs formulated with polysorbate 80
boolean
C0020517 (UMLS CUI [1,1])
C0246415 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0032601 (UMLS CUI [2,2])
C1705957 (UMLS CUI [2,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video